KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Cash (2016 - 2025)

Thermo Fisher Scientific's Change in Cash history spans 17 years, with the latest figure at $7.9 billion for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 1348.89% year-over-year to $7.9 billion, compared with a TTM value of $5.8 billion through Dec 2025, up 243.92%, and an annual FY2025 reading of $5.8 billion, up 243.92% over the prior year.
  • Change in Cash for Q4 2025 was $7.9 billion at Thermo Fisher Scientific, up from -$2.6 billion in the prior quarter.
  • The five-year high for Change in Cash was $7.9 billion in Q4 2025, with the low at -$7.6 billion in Q4 2021.
  • Average Change in Cash over 5 years is -$22.8 million, with a median of -$107.5 million recorded in 2023.
  • Year-over-year, Change in Cash plummeted 904.93% in 2021 and then soared 1348.89% in 2025.
  • Tracing TMO's Change in Cash over 5 years: stood at -$7.6 billion in 2021, then skyrocketed by 174.14% to $5.6 billion in 2022, then crashed by 65.57% to $1.9 billion in 2023, then tumbled by 132.66% to -$630.0 million in 2024, then soared by 1348.89% to $7.9 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Change in Cash are $7.9 billion (Q4 2025), -$2.6 billion (Q3 2025), and $431.0 million (Q2 2025).